HLA-DQB1*0602 allele is associated with splenomegaly in Japanese sarcoidosis

Journal of Internal Medicine

Volumn 262, Issue 4, 2007, Pages 449-457

  Sato, H ^a,d   Nagai, S ^b,c   Du Bois, R M ^a   Handa, T ^b   Suginoshita, Y ^b   Ohta, K ^c   Welsh, K I ^a   Izumi, T ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b KYOTO UNIVERSITY   (Japan)

^c Central Clinic in Kyoto   (Japan)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Genetic; HLA class II; Sarcoidosis; Splenomegaly

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN;

ADULT; ALLELE; ANGIOTENSIN BLOOD LEVEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; GENOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SARCOIDOSIS; SPLENOMEGALY; THORAX RADIOGRAPHY;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; SARCOIDOSIS, PULMONARY; SPLENOMEGALY;

EID: 34548622281     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2007.01829.x     Document Type: Article

References (25)

1. Folz SJ, Johnson CD, Swensen SJ. Abdominal manifestations of sarcoidosis in CT studies. J Comput Assist Tomogr 1995 19 : 573 9.
2. Kataoka M, Nakata Y, Maeda T et al. Ultrasonographic analysis of splenomegaly in patients with sarcoidosis. Nihon Kyobu Shikkan Gakkai Zasshi 1990 28 : 750 5.
3. Warshauer DM, Semelka RC, Ascher SM. Nodular sarcoidosis of the liver and spleen: appearance on MR images. J Magn Reson Imaging 1994 4 : 553 7.
4. Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J 1999 14 : 735 7.
5. Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997 156 : 1601 5.
6. Foley PJ, McGrath DS, Puscinska E et al. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am J Respir Cell Mol Biol 2001 25 : 272 7.
7. Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 2004 169 : 696 702.
8. Rossman MD, Thompson B, Frederick M et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 2003 73 : 720 35.
9. Rutherford RM, Brutsche MH, Kearns M, Bourke M, Stevens F, Gilmartin JJ. HLA-DR2 predicts susceptibility and disease chronicity in Irish sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2004 21 : 191 8.
10. Sato H, Grutters JC, Pantelidis P et al. HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Biol 2002 27 : 406 12.
11. Voorter CE, Drent M, Hoitsma E, Faber KG, van den Berg-Loonen EM. Association of HLA DQB1 0602 in sarcoidosis patients with small fiber neuropathy. Sarcoidosis Vasc Diffuse Lung Dis 2005 22 : 129 32.
12. Iannuzzi MC, Maliarik MJ, Poisson LM, Rybicki BA. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med 2003 167 : 1225 31.
13. Coakley G, Brooks D, Iqbal M et al. Major histocompatility complex haplotypic associations in Felty's syndrome and large granular lymphocyte syndrome are secondary to allelic association with HLA-DRB1 *0401. Rheumatology (Oxford) 2000 39 : 393 8.
14. Turesson C, Schaid DJ, Weyand CM et al. The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis. Arthritis Res Ther 2005 7 : R1386 93.
15. Bhatia K, Crane G. HLA and tropical splenomegaly syndrome in the Upper Watut Valley of Papua New Guinea. Hum Immunol 1985 13 : 235 42.
16. Lamb PM, Lund A, Kanagasabay RR, Martin A, Webb JA, Reznek RH. Spleen size: how well do linear ultrasound measurements correlate with three-dimensional CT volume assessments? 1. Br J Radiol 2002 75 : 573 7.
17. Yoshimastu E, Kusuhara K, Igarashi T et al. Evaluation for ultrasonographic measurement of spleen. Choonpa kensa gijyutsu 2004 29 : 821 4.
18. Kasahara Y, Ashihara Y. Colorimetry of angiotensin-I converting enzyme activity in serum. Clin Chem 1981 27 : 1922 5.
19. Bunce M, O'Neill CM, Barnardo MC et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995 46 : 355 67.
20. Welsh K, Bunce M. Molecular typing for the MHC with PCR-SSP. Rev Immunogenet 1999 1 : 157 76.
21. Saito S, Ota S, Yamada E, Inoko H, Ota M. Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens 2000 56 : 522 9.
22. Crane G. The genetic basis of hyperreactive malarious splenomegaly. P N G Med J 1989 32 : 269 76.
23. Duric B, Secen N. Sarcoidosis activity markers. Med Pregl 1991 44 : 259 62.
24. Madaule S, Lauque D, Sailler L, Arlet P, Carles P. Splenomegaly in sarcoidosis: clinical features and outcome Analysis of 17 cases. Rev Med Interne 2004 25 : 348 56.
25. Mana J, Salazar A, Manresa F. Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases. Respiration 1994 61 : 219 25.